Variable | Ceftriaxone (Group A) | Cefepime (Group B) | P-value |
---|---|---|---|
N = 113 | N = 117 | ||
Increasing tenderness | |||
Absent | 111 (98.23 %) | 113 (96.58 %) | 0.81 |
Present | 1 (0.9 %) | 3 (2.6 %) | |
Indeterminate | 1 (0.9 %) | 1 (0.9 %) | |
Morbid fever | |||
Absent | 112 (99.12 %) | 112 (95.73 %) | 0.122 |
Present | 0 (0.00 %) | 4 (3.43 %) | |
Indeterminate | 1 (0.9 %) | 1 (0.9 %) | |
0 | 0 | ||
Wound dehiscence | |||
Present | 3 (2.65 %) | 5 (4.27 %) | 0.380 |
Absent | 110 (97.35 %) | 112 (95.73 %) | |
Occupied Bed Days | |||
1–5 days | 68 (60.2 %) | 58 (49.6 %) | 0.211 |
6–10 days | 43 (38.0 %) | 45 (38.5 %) | |
11–15 days | 2 (1.80 %) | 13 (11.1 %) | |
Primary outcome (SSI) | |||
Absent | 110 (97.35 %) | 112 (95.73 %) | 0.380 |
Present | 3 (2.65 %) | 5 (4.27 %) |